home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
FLARE THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $123 MILLION SERIES B FINANCING
FLARE THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $123 MILLION SERIES B FINANCING
Post navigation
Previous Post
Previous
Kinnate Biopharma Inc. Provides Full-Year 2022 Financial Results and Recent Corporate Updates
Next Post
Next
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights